Beam Therapeutics Inc.
BEAM
31 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Feb 26 9:05 PM | Giuseppe CiaramellaPresident | Sale | 35,000 | $32.00 | $1.1M | 190,216(D) | View → |
| Feb 24, 2026 | Feb 24 9:15 PM | GIUSEPPE CIARAMELLA | Proposed Sale | 35,000 | $32.00 | $1.1M | — | View → |
| Jan 30, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Sale | 25,000 | $28.36 | $708.9K | 986,667(D) | View → |
| Jan 29, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Sale | 25,000 | $29.38 | $734.6K | 986,667(D) | View → |
| Jan 30, 2026 | Jan 30 9:04 PM | JOHN M EVANS | Proposed Sale | 25,000 | $28.36 | $708.9K | — | View → |
| Jan 29, 2026 | Jan 29 9:01 PM | JOHN M EVANS | Proposed Sale | 25,000 | $29.38 | $734.6K | — | View → |
| Jan 22, 2026 | Jan 26 9:05 PM | Bethany J CavanaghSVP, Finance and Treasurer | Sale | 6,198 | $35.00 | $216.9K | 34,813(D) | View → |
| Jan 22, 2026 | Jan 26 9:05 PM | Christine BellonChief Legal Officer | Sale | 1,371 | $34.00 | $46.6K | 95,667(D) | View → |
| Jan 22, 2026 | Jan 22 9:03 PM | CHRISTINE BELLON | Proposed Sale | 1,371 | $34.00 | $46.6K | — | View → |
| Jan 20, 2026 | Jan 21 9:05 PM | Bethany J CavanaghSVP, Finance and Treasurer | Sale | 3,034 | $30.12 | $91.4K | 41,011(D) | View → |
| Jan 15, 2026 | Jan 20 9:05 PM | Christine BellonChief Legal Officer | Sale | 18,629 | $34.61 | $644.8K | 97,038(D) | View → |
| Jan 15, 2026 | Jan 15 11:00 PM | CHRISTINE BELLON | Proposed Sale | 18,629 | $34.61 | $644.8K | — | View → |
| Oct 2, 2025 | Oct 2 8:23 PM | JOHN M EVANS | Proposed Sale | 25,000 | $24.63 | $615.7K | — | View → |
| Oct 1, 2025 | Oct 1 8:12 PM | JOHN M EVANS | Proposed Sale | 25,000 | $24.51 | $612.7K | — | View → |
| Apr 2, 2025 | Apr 2 8:08 PM | AMY SIMON | Proposed Sale | 20,997 | $17.73 | $372.3K | — | View → |
| Apr 1, 2025 | Mar 31 10:44 PM | AMY SIMON | Proposed Sale | 30,562 | $22.21 | $678.8K | — | View → |
| Apr 1, 2025 | Mar 31 10:43 PM | JOHN M. EVANS | Proposed Sale | 64,842 | $22.21 | $1.4M | — | View → |
| Apr 1, 2025 | Mar 31 10:43 PM | CHRISTINE BELLON | Proposed Sale | 18,125 | $22.21 | $402.6K | — | View → |
| Apr 1, 2025 | Mar 31 10:43 PM | GIUSEPPE CIARAMELLA | Proposed Sale | 23,750 | $22.21 | $527.5K | — | View → |
| Feb 14, 2025 | Feb 14 9:06 PM | CHRISTINE BELLON | Proposed Sale | 10,000 | $34.00 | $340.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $1.03 | 205,804(D) | View → |
| Jun 29, 2026 | Jul 1 8:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $1.03 | 230,804(D) | View → |
| Jun 17, 2026 | Jun 22 8:05 PM | Giuseppe CiaramellaPresident | Option Exercise | 35,505 | $1.03 | 56,946(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Christi ShawDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Kathleen E WalshDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | John MaraganoreDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Mark FishmanDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Chirfi GuindoDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Jun 3, 2026 | Jun 5 8:05 PM | Graham K CooperDirector | Grant/Award | 19,676 | $29.55 | 19,676(D) | View → |
| Mar 31, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 18,672(D) | View → |
| Mar 30, 2026 | Apr 1 10:32 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 43,672(D) | View → |
| Feb 24, 2026 | Feb 26 9:05 PM | Giuseppe CiaramellaPresident | Option Exercise | 35,000 | $17.00 | 397,313(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Bethany J CavanaghSVP, Finance and Treasurer | Grant/Award | 40,000 | $27.62 | 40,000(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Giuseppe CiaramellaPresident | Grant/Award | 80,000 | $27.62 | 80,000(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Sravan Kumar EmanyChief Financial Officer | Grant/Award | 63,500 | $27.62 | 63,500(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Christine BellonChief Legal Officer | Grant/Award | 40,000 | $27.62 | 40,000(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Grant/Award | 180,000 | $27.62 | 180,000(D) | View → |
| Jan 30, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 68,672(D) | View → |
| Jan 29, 2026 | Feb 2 9:05 PM | John M. EvansDirector, CEO | Option Exercise | 25,000 | $0.67 | 93,672(D) | View → |
| Jan 31, 2026 | Feb 2 9:05 PM | Amy SimonChief Medical Officer | Grant/Award | 88,500 | $27.62 | 88,500(D) | View → |